The following is a quick round up of eLife developments, which was sent to our news subscribers. Didn't receive a copy? Subscribe to eLife News now. If you have any questions or comments, feel free to contact us.
Curious? Learn more about eLife the funder-research collaboration for the best in science
eLife is holding an online Open House to share news on the development of its anticipated open-access journal for the very best in life science and biomedical research. Learn more at http://www.elifesciences.org/open-house.
Find eLife at the #IUBMBFEBS2012 meeting in Seville this week
We'll be in the exhibit hall (#N41) and senior editor Janet Rossant will be speaking on Friday. See the details at http://www.iubmb-febs-2012.org.
This month on Twitter with @eLife_sciences: Sensationalization and impact factor
Join us. https://twitter.com/elife_sciences
A flavor of things to come
The authors of one of eLife's earliest accepted articles,Bacterial regulation of colony development in the closest living relatives of animals, made their manuscript openly available following an expression of interest from the media. Explore the extensive press coverage that followed and what it means for eLife.
Send your papers now
Now is the time to submit your very best work for consideration by the much anticipated journal being launched by three of the world’s most prestigious biomedical research funders:eLife. Hear more from editor-in-chief Randy Schekman at http://www.elifesciences.org/send-your-papers-now.
Questions & answers
We’ve posted eLife answers to important questions about our launch date, post-docs, open-access publishers, funding relationships, and more. Take a look at http://www.elifesciences.org/about/frequently-asked-questions.
eLife Newswill be published periodically throughout 2012 to update subscribers on the development of the anticipatedeLifejournal. Questions and comments related to the content may be addressed to media@elifesciences.org or through http://www.elifesciences.org/contact.
© eLife Sciences Publications Ltd, subject to a Creative Commons Attribution License.
